Kensei Yamaguchi

31PUBLICATIONS
192CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer geneticsDependable systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|May 27, 2026
High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer.

|May 04, 2026
A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA.

|Mar 30, 2026
Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy.

Yuqing Duan, Tadayoshi Hashimoto, Taro Shibuki

|Mar 15, 2026
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.

Takeru Wakatsuki, Noriko Yamamoto, Naoki Ishizuka

|Nov 18, 2025
Impact of total neoadjuvant therapy regimens on radiation-induced lymphopenia in locally advanced rectal cancer: a retrospective analysis.

Rie Sasaki, Senzo Taguchi, Hikaru Miyauchi

|Nov 04, 2025
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2024 for the treatment of colorectal cancer.

Yusuke Kinugasa, Kay Uehara, Kensei Yamaguchi

Pageof 6

Frequent Collaborators

8 joint publications

Eiji Shinozaki

8 joint publications

Hiroki Osumi

7 joint publications

Takeru Wakatsuki

6 joint publications

Keisho Chin